Kallisio develops patient-specific medical devices for oncology, led by Stentra™, an FDA-cleared and CE-marked intraoral device custom-made for head and neck radiation therapy. Designed from a patient’s oral scan and delivered within 72 hours, Stentra™ helps position the tongue and protect healthy tissue without disrupting standard clinical workflows. The Baltimore company is building a broader pipeline of personalized precision-care solutions with clinicians and medical centers.
FDA Registered
registration
CE Marked
certification
ISO 13485
certification
HIPAA-Compliant Workflow
compliance_program